Jonsson Comprehensive Cancer Center
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.cancer.ucla.edu
A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer
- Conditions
- Skin Carcinoma
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT07032701
- Locations
- πΊπΈ
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
- Conditions
- Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 80
- Registration Number
- NCT06995053
- Locations
- πΊπΈ
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Ivonescimab for the Treatment of Thymic Cancer
- Conditions
- Thymus Carcinoma
- Interventions
- Procedure: Biopsy ProcedureProcedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Magnetic Resonance ImagingOther: Questionnaire Administration
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT06980077
- Locations
- πΊπΈ
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Impact of Artificial Intelligence on Breast Cancer Screening
- Conditions
- Breast Cancer ScreeningArtificial Intelligence (AI)
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 154474
- Registration Number
- NCT06934239
- Locations
- πΊπΈ
University of California Los Angeles Health System, Los Angeles, California, United States
πΊπΈUniversity of Washington Health System, Seattle, Washington, United States
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
- Conditions
- T-cell-prolymphocytic LeukemiaCutaneous T-Cell Lymphoma Refractory
- Interventions
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT06810778
- Locations
- πΊπΈ
David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, California, United States
Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms
- Conditions
- DLL3-expressing TumorsAdvanced Tumors
- Interventions
- Drug: Tarlatamab treatment
- First Posted Date
- 2025-01-23
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT06788938
- Locations
- πΊπΈ
University of California at San Francisco, San Francisco, California, United States
πΊπΈUC Davis Comprehensive Cancer Center, Davis, California, United States
πΊπΈUCI Health Chao Family Comprehensive Cancer Center, Irvine, California, United States
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
- Conditions
- GliomaMalignant Brain NeoplasmMeningiomaMetastatic Malignant Neoplasm in the Brain
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06650163
- Locations
- πΊπΈ
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)
- Conditions
- Head and Neck CarcinomaLocalized Head and Neck CarcinomaMetastatic Head and Neck CarcinomaRecurrent Head and Neck Carcinoma
- Interventions
- Procedure: Personalized ultrafractionated stereotactic adaptive radiotherapyRadiation: Volume Modulated Arc TherapyProcedure: Computed TomographyProcedure: Positron Emission TomographyProcedure: Magnetic Resonance ImagingOther: Best PracticeBehavioral: University of Washington Quality of Life Scale, Version 4Behavioral: Functional Assessment of Cancer Therapy-Head & Neck
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 43
- Registration Number
- NCT06572423
- Locations
- πΊπΈ
University of California at Los Angeles, Los Angeles, California, United States
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
- Conditions
- Colorectal Carcinoma
- Interventions
- Other: Best PracticeOther: Communication InterventionOther: Electronic Health Record ReviewOther: CoordinationOther: Educational InterventionOther: InterviewOther: ReferralOther: Informational InterventionBehavioral: Patient NavigationOther: Text Message-Based Navigation Intervention
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 1500
- Registration Number
- NCT06568016
- Locations
- πΊπΈ
University of California at Los Angeles, Los Angeles, California, United States
πΊπΈUCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
- Conditions
- Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell CarcinomaStage IVB Cervical Cancer American Joint Committee on Cancer (AJCC) v8
- Interventions
- Procedure: Biospecimen CollectionRadiation: BrachytherapyRadiation: External Beam Radiation TherapyOther: Questionnaire Administration
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT06543576
- Locations
- πΊπΈ
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
πΊπΈUniversity of California San Diego (UCSD), San Diego, California, United States
πΊπΈUniversity of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States